0.00Open0.00Pre Close0 Volume0 Open Interest9.00Strike Price0.00Turnover0.00%IV-56.79%PremiumSep 20, 2024Expiry Date3.26Intrinsic Value100Multiplier10DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.74Leverage Ratio--Theta--Rho--Eff Leverage--Vega
jebadia frobe : my gf is a transplant recipient and this kind of innovation and science is needed and sooo important.
she had a liver disease that she was born with subsequently she did not only have one transplant but 4 from birth to the age of 16. this kind of technology would have been able to create a perfect match and would have saved her so much trauma. maybe it's wrong to make stock trading investments personal but for this company I'll allow it. thank you RDW
Jaguar8 OP jebadia frobe : No it’s ok to have some personal preference for stocks. I myself have preference to biotech stocks because one, I’m a medical provider and second I’m battling stage 4 cancer, and third my family has history of CA, DM, heart disease. So any advancements for diseases I really rejoice at.
Arrayfunction : This is actually the coolest trial I have ever heard of! I actually took part in a team research project for NASA's zero gravity undergraduate research project (which gets zero gravity by flying in steep parabolas rather than being in space) trying to look at how osteoblasts behaved differently to address bone loss for astronauts.
It is very interesting how so much of the biochemistry is affected by gravity (and how things like electrostatic interactions and Brownian motion become far more important in zero gravity). I am not 100% sure how this experiment will impact the organ printing industry commercially, but it will be a lot of fun to see what the results are!
Thanks for sharing